Skip to main content
. 2012 Feb 8;35(3):180–186. doi: 10.1002/clc.21969

Table 1.

Studies to Date on Atrial Fibrillation and Acid Reflux Disease

Study Authors Nature of the Study No. of Patients Methodology Results Conclusion
Tougas et al, 199722 Observational, prospective. Fourteen healthy volunteers Heart rate variability was compared at rest and during esophageal stimulation, using either electrical or mechanical stimuli. Decreased heart rate (both electrical and mechanical) (P < 0.005), and altered heart rate variability (P < 0.001). Increased absolute and normalized area of the high‐frequency band within the power spectrum (P < 0.001). Decreasing the low‐frequency power (P < 0.005). Esophageal stimulation (electrical or mechanical) appears to amplify respiratory‐driven cardiac vagoafferent modulation while decreasing sympathetic modulation.
Weigl et al, 200330 Observational, retrospective. Eighteen patients with paroxysmal AF. Upper endoscopic examination showed that 14 patients had esophagitis and the other 4 had Barrett esophagus. All patients received daily or twice‐daily PPI therapy. Decrease or disappearance of at least 1 PAF‐related symptom occurred in 14 of 18 patients (78%) after PPI therapy. In 2 of the remaining 4 patients, GERD‐related symptoms persisted. Antiarrhythmic drugs were discontinued in 5 patients, and none had to be increased in dosage or newly prescribed. ECG showed sinus rhythm in all patients. GERD should be investigated as a potential pathogenetic mechanism in lone PAF. PPI therapy reduces not only GERD‐related but also PAF‐related symptoms.
Cuomo et al, 200631 Observational, prospective. Thirty‐two patients with GERD and dysarrhtyhmias and 9 with GERD. Power spectrum analysis of heart rate variability was obtained with both its LF (sympathetic modulation) and HF (vagal modulation) components. Hourly mean esophageal pH and LF/HF ratio (esophagus‐heart) were correlated. A 3‐month regimen of esomeprazole 40 mg/day was prescribed. In 8 (56%) of the 32 patients with dysrhythmia and in none with GERD only, a significant correlation between esophageal pH and LF/HF ratio was observed. A significant reduction of cardiac symptoms after PPI therapy was observed only in these patients (13/16 vs 4/11, P < 0.01). Subgroup of dysrhythmic patients in whom the esophageal acid stimulus elicited cardiac autonomic reflexes. In these patients, acid suppression seems to improve GERD and cardiac symptoms.
Gerson et al, 200632 Observational, prospective. All 3 patients had heartburn, acid regurgitation, and palpitations occurring at least weekly and reported a potential association between the palpitations and GERD symptoms. The patients underwent simultaneous 24‐hour esophageal ambulatory pH and Holter monitoring off of antireflux therapy for at least 7 days to investigate a potential relationship between GERD symptoms and the presence of cardiac arrhythmic events. All of the patients reported a reduction in arrhythmia symptoms on PPI. Atrial arrhythmia and reflux should have a trial of aggressive acid suppressive therapy.
Bunch et al, 200834 Observational, prospective. A total of 5288 residents (age 25–74 years) of Olmsted County, Minnesota, to assess the presence and frequency of GERD from 1988–1994. A self‐report questionnaire was mailed to a random sample. GERD was not associated with risk for AF (HR: 0.81, 95% CI: 0.68–0.96, P  = 0.014) after adjustment for other risk factors. Patients with more frequent GERD had a slightly higher nonsignificant AF risk. Esophagitis increased the risk for AF (HR: 1.94, 95% CI: 1.35–2.78, P < 0.001), but the association did not persist when accounting for other risk factors. No association was found with the presence of GERD or the frequency of symptoms and AF. Patients with esophagitis were more likely to develop AF.
Kunz et al, 200935 Retrospective. There were 163627 patients of which 7992 (5%) had AF and 47845 (29%) had GERD. Database containing all healthcare encounters for patients who received ambulatory care in the National Capitol Region military healthcare system between January 1, 2001 and October 28, 2007. The presence of GERD increased the RR of a diagnosis of AF (RR: 1.39, 95% CI: 1.33–1.45). In sensitivity analyses, this relationship persisted after adjustment for cardiovascular disease risk factors (RR: 1.19, 95% CI: 1.13–1.25) and diagnoses known to be strongly associated with AF (RR: 1.08, 95% CI: 1.02–1.13). GERD is associated with an increased risk of a diagnosis of AF.
Shimazu et al, 201136 Retrospective. There were 188 subjects treated for GERD as outpatients Patients were classified by the frequency scale for symptoms of GERD (F scale). Total scores on the F scale were significantly greater in patients with AF (P  = 0.019) compared to other subjects. Univariate and multivariate analysis of the prevalence of GERD demonstrated AF alone showed a significant (P < 0.001) correlation with GERD. AF was an independent risk factor for GERD.

Abbreviations: AF, atrial fibrillation; CI, confidence interval; ECG, electrocardiogram; GERD, gastroesophageal reflux disease; HF, high frequency; HR, hazard ratio; LF, low frequency; PAF, paroxysmal atrial fibrillation; PPI, proton pump inhibitor; RR, relative risk.